The more you understand about primary immunodeficiency (PI), the better you can live with the disease or support others in your life with PI. Learn more about PI, including the various diagnoses and treatment options.
Living with primary immunodeficiency (PI) can be challenging, but you’re not alone—many people with PI lead full and active lives. With the right support and resources, you can, too.
Be a hero for those with PI. Change lives by promoting primary immunodeficiency (PI) awareness and taking action in your community through advocacy, donating, volunteering, or fundraising.
Whether you’re a clinician, researcher, or an individual with primary immunodeficiency (PI), IDF has resources to help you advance the field. Get details on surveys, grants, and clinical trials.
IDF has launched a new and improved resource for individuals living with PI who rely on immunoglobulin (Ig) treatment, Characteristics of Ig Products Used to Treat PI Licensed for Use in the US. Formerly presented as an Ig product chart, the information has been updated to a booklet with an all-new look, the latest up-to-date information and interactive web features.
The upgraded resource contains helpful information about Ig products in one, easy-to-read booklet, including the method of administration, shelf-life storage requirements, available concentrations and much more.
Whether you have been recently diagnosed or want to learn about Ig products on the market, this resource can help you make an informed decision about what works best for you and can be quickly downloaded and accessed from the IDF website.
To download the booklet, titled Characteristics of Ig Products Used to Treat PI Licensed for Use in the US, please click here.
Receive news and helpful resources to your cell phone or inbox. You can change or cancel your subscription at any time.
The Immune Deficiency Foundation improves the diagnosis, treatment, and quality of life for every person affected by primary immunodeficiency.
We foster a community that is connected, engaged, and empowered through advocacy, education, and research.
Combined Charity Campaign | CFC# 66309